Close Menu

This article has been updated with additional information from Centogene's earnings call.

NEW YORK – Centogene on Wednesday morning reported a 13 percent year-over-year decrease in second quarter revenues, resulting from a drop in sample volumes related to the COVID-19 pandemic that was partially offset by additional revenues from coronavirus diagnostic testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.